Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Moderna exec: 'eager' to collaborate with China on supplying COVID vaccines

Published 09/21/2022, 08:26 AM
Updated 09/21/2022, 02:53 PM
© Reuters
MRNA
-

TOKYO (Reuters) - Moderna (NASDAQ:MRNA) Inc Chief Medical Officer Paul Burton said on Wednesday the company is "eager" to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

© Reuters. FILE PHOTO: People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration

The comments follow those of Moderna chief executive Stephane Bancel, who last week in Tokyo said the company has held talks with the Chinese government about supplying vaccines but no decision has yet been made.

"We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there," Burton told a media briefing to reporters in Asia. "Currently, there is no activity going on, but we'd be very open to it."

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.